Osteoporosis Drugs Market Worldwide Industry Analysis

1
The global osteoporosis drugs market was valued
at 8,835.4 million in 2015 and it is expected to
grow at a CAGR of 3.8 during 2016-2022.
2
The global osteoporosis drugs market was valued
at 8,835.4 million in 2015 and it is expected to
grow at a CAGR of 3.8 during 2016-2022. Among
the various classes of osteoporosis drugs, the
rank ligand inhibitor segment is expected to
witness the fastest growth, a CAGR of 4.3 during
the forecast period. The global osteoporosis
drugs market is growing at a significant rate due
to growing geriatric population, increasing
awareness of osteoporosis and increasing
healthcare expenditure. The increasing prevalence
of osteoporosis in postmenopausal women and the
increasing focus on research development of new
drugs for treatment of osteoporosis are also
driving the growth of the global osteoporosis
drugs market. Access Detailed Report Summary at
https//www.psmarketresearch.com/market-analysis/o
steoporosis-drugs-market

3
The information and data in the publication
Global Osteoporosis Drugs Market Size, Share,
Development, Growth and Demand Forecast to 2022
represent the research and analysis of data from
various primary and secondary sources. The
bottom-top approach has been used to calculate
the global market size by drug class. PS
Intelligence analysts and consultants interacted
with authorities from leading companies of the
concerned domain to substantiate every value of
data presented in the report. The company bases
its primary research on discussions with
prominent professionals and analysts in the
industry, which is followed by informed and
detailed online and offline research. Download
Report Sample at https//www.psmarketresearch.com
/market-analysis/osteoporosis-drugs-market/report-
sample

4
Geographically, North America dominated the
global market of osteoporosis drugs in 2015
whereas the Asia-Pacific market is expected to
witness the fastest growth, a CAGR of 4.2 during
the forecast period. This is due to the growing
geriatric population, increasing awareness of
osteoporosis drugs and increasing healthcare
expenditure in the region. Some of the key
companies operating in the global osteoporosis
drugs market include Eli Lilly and Company,
Pfizer Inc., F. Hoffmann-La Roche, Novartis
International AG, Merck Co. Inc. and Amgen Inc.

5
THANK YOU!
For queries, kindly write to
enquiry_at_psmarketresearch.com
GET IN TOUCH
www.psmarketresearch.com
B-13, Sector-2, Noida, U.P.-201301, INDIA Contact
No 91 120 4541 337 US/Canada Toll-Free
1-888-778-7886  
US/Canada Toll-Free 1-888-778-7886